https://health.economictimes.indiatimes.com/news/pharma/drug-approvals-launches/eu-drug-watchdog-approves-first-rsv-infant-elderly-vaccine/102027652
0
0
43 words
0
Comments
RSV normally causes mild, cold-like symptoms, but can be serious for infants, the elderly, those with weak immune systems and underlying conditions. It is a leading cause of paediatric hospitalisation in Europe.
You are the first to view
Create an account or login to join the discussion